China’s Mindray Medical Views International Expansion As Key To Growth
This article was originally published in The Gray Sheet
Executive Summary
Mindray Medical plans to build on its status as China's largest device company by growing its overseas presence while expanding its core patient monitoring, diagnostic and ultrasound imaging product offerings, the firm says
You may also be interested in...
U.S. Set To Ink Agreement Tightening China’s Device Exports Standards
Health and Human Services Secretary Mike Leavitt expects to finalize a binding agreement for medical device and drug safety during his trip to China this week
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.